Abstract

BackgroundAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the death of neurons. ALS is associated with many gene mutations as previously studied. In order to explore the molecular mechanisms underlying ALS with C9orf72 mutation, gene expression profiles of ALS fibroblasts and control fibroblasts were subjected to bioinformatics analysis. Genes with critical functional roles can be detected by a measure of node centrality in biological networks. In gene co-expression networks, highly connected genes called as candidate hubs have been associated with key disease-related pathways. Herein, this method was applied to find the hub genes related to ALS disease.MethodsIllumina HiSeq microarray gene expression dataset GSE51684 was retrieved from Gene Expression Omnibus (GEO) database which included four Sporadic ALS, twelve Familial ALS and eight control samples. Differentially Expressed Genes (DEGs) were identified using the Student’s t test statistical method and gene co-expression networking. Gene ontology (GO) function and KEGG pathway enrichment analysis of DEGs were performed using the DAVID online tool. Protein-protein interaction (PPI) networks were constructed by mapping the DEGs onto protein-protein interaction data from publicly available databases to identify the pathways where DEGs are involved in. PPI interaction network was divided into subnetworks using MCODE algorithm and was analyzed using Cytoscape.ResultsThe results revealed that the expression of DEGs was mainly involved in cell adhesion, cell-cell signaling, Extra cellular matrix region GO processes and focal adhesion, neuroactive ligand receptor interaction, Extracellular matrix receptor interaction. Tumor necrosis factor (TNF), Endothelin 1 (EDN1), Angiotensin (AGT) and many cell adhesion molecules (CAM) were detected as hub genes that can be targeted as novel therapeutic targets for ALS disease.ConclusionThese analyses and findings enhance the understanding of ALS pathogenesis and provide references for ALS therapy.Electronic supplementary materialThe online version of this article (doi:10.1186/s13023-016-0531-y) contains supplementary material, which is available to authorized users.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the death of neurons

  • Statistical methods used in the present study could identify more number of Differentially expressed genes (DEG) when compared to the DEGs reported by Lagier-Tourenne et al [16]

  • Several important DEGs were identified, including Tumor necrosis factor (TNF), Endothelin 1 (EDN1), Angio tensin (AGT), Apolipoprotein E (APOE), Vitronectin (V TN), Von Willebrand factor (VWF), Thrombospondin receptor (CD36), TNF Receptor Superfamily Member 5 (CD40), Integrin, Alpha 3 (ITGA3), Integrin, Alpha 7 (IT GA7), Transforming growth factor beta 2 (TGFB2), Aggrecan (ACAN),Wingless-Type MMTV Integration site fam ily, member 5A (WNT5A), Neurotrophic tyrosine kinase, receptor, type 2 (NTRK2) and Zinc finger protein GLI1 (GLI1) which were involved in the biological processes related to ALS

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves the death of neurons. In gene co-expression networks, highly connected genes called as candidate hubs have been associated with key disease-related pathways. Findings on ALS patients have drawn in numerous genes related to ALS pathogenesis and have identified diverse processes, such as excitotoxicity, oxidative stress, cytoskeletol abnormalities, impaired axonal transport, mitochondrial dysfunction and protein aggregation. Till date studies were done to know the molecular mechanisms and underlying pathogenesis of ALS disease related to SALS with Superoxide dismutase 1 (SOD1) mutation [5, 6]. As the study of SOD1 has led to great advances in proper illustration of molecular mechanisms underlying in ALS disease, identifying the mutations in other genes and the pathways involved in these mechanisms is utmost important. Improving diagnoses and treatment of this disease is utmost essential, as currently there exists no cure for ALS

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call